Trial Details

RECRUITING
Basic Information
Clinical ID c954
Identifier NCT05770609
Trial Title A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Mild to Moderate Ulcerative Colitis
Interventions DRUG: SPH3127 Tablets with Dose A|DRUG: SPH3127 Tablets with Dose B|DRUG: SPH3127 Tablets placebo
Participant Information
Sponsor Shanghai Pharmaceuticals Holding Co., Ltd
City Guangzhou
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-06-19 00:00:00.000000
Primary Completion Date 2025-02-15 00:00:00.000000
Completion Date 2025-02-15 00:00:00.000000